IIM
KZR

Ironwood Investment Management’s Kezar Life Sciences KZR Stock Holding History

Ironwood Investment Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,842
Closed -$22K – 173
2024
Q3 		$22K Buy
2,842
+141
+5% +$850 0.01% 172
2024
Q2 		$16.2K Sell
2,701
-100
-4% -$760 0.01% 168
2024
Q1 		$25.3K Buy
2,801
+286
+11% +$2.6K 0.01% 173
2023
Q4 		$23.8K Sell
2,515
-346
-12% -$3.04K 0.01% 166
2023
Q3 		$34K Sell
2,861
-1
-0% -$18 0.02% 161
2023
Q2 		$70.1K Sell
2,862
-139
-5% -$3.62K 0.04% 162
2023
Q1 		$93.9K Buy
3,001
+93
+3% +$5.38K 0.06% 157
2022
Q4 		$205K Sell
2,908
-200
-6% -$14.8K 0.14% 142
2022
Q3 		$268K Buy
3,108
+7
+0.2% +$680 0.19% 128
2022
Q2 		$256K Buy
3,101
+4
+0.1% +$353 0.17% 133
2022
Q1 		$515K Buy
3,097
+31
+1% +$4.45K 0.28% 114
2021
Q4 		$513K Buy
+3,066
New +$346K 0.25% 119

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ironwood Investment Management's KZR Position: Q4 2024 in Review

Ironwood Investment Management sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 2,842 shares — an estimated $22K sold.

Ironwood Investment Management first reported a position in KZR in Q4 2021 and held it in 12 quarters. The position peaked at $515K in Q1 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Ironwood Investment Management reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Ironwood Investment Management sold 2,842 Kezar Life Sciences shares in Q4 2024, an estimated $22K.
  • Ironwood Investment Management first reported a position in Kezar Life Sciences in Q4 2021 and held it in 12 quarters.
  • Ironwood Investment Management's Kezar Life Sciences position peaked at $515K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Ironwood Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.